Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease

Circulation: Cardiovascular Imaging

Volumn 8, Issue 4, 2015, Pages

  Wells, J Michael ^a,b,c   Iyer, Anand S ^b   Rahaghi, Farbod N ^f   Bhatt, Surya P ^b,c   Gupta, Himanshu ^a,b,d   Denney, Thomas S ^g   Lloyd, Steven G ^a,b,d   Dell'Italia, Louis J ^a,b,d   Nath, Hrudaya ^e   Estepar, Raul San Jose ^f   Washko, George R ^f   Dransfield, Mark T ^a,b,c  

^a BIRMINGHAM VA MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d University of Alabama at Birmingham and Birmingham Veterans Affairs Medical Center   (United States)

^e University of Alabama at Birmingham   (United States)

^f BRIGHAM AND WOMEN S HOSPITAL   (United States)

^g AUBURN UNIVERSITY   (United States)

Author keywords

cardiac magnetic resonance imaging; hypertension, pulmonary; pulmonary disease; pulmonary heart disease; smoking

Indexed keywords

6 MINUTE WALK DISTANCE; ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; EMPHYSEMA; EXERCISE; EXERCISE TOLERANCE; FEMALE; FORCED EXPIRATORY VOLUME; FUNCTION TEST; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE ENDDIASTOLIC VOLUME; HEART RIGHT VENTRICLE ENDSYSTOLIC VOLUME; HEART RIGHT VENTRICLE FAILURE; HEART RIGHT VENTRICLE FUNCTION; HEART RIGHT VENTRICLE VOLUME; HUMAN; HYPERINFLATION; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY ARTERY TO ASCENDING AORTA DIAMETER RATIO; PULMONARY BLOOD VESSEL VOLUME; PULMONARY HYPERTENSION; RESTING HEART RATE; THREE DIMENSIONAL IMAGING; AGED; BLOOD VOLUME; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; PULMONARY ARTERY;

AGED; BLOOD VOLUME; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PULMONARY ARTERY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84937685599     PISSN: 19419651     EISSN: 19420080     Source Type: Journal    
DOI: 10.1161/CIRCIMAGING.114.002546     Document Type: Article

References (41)

1. Wells JM, Washko GR, Han MK, Abbas N, Nath H, Mamary AJ, Regan E, Bailey WC, Martinez FJ, Westfall E, Beaty TH, Curran-Everett D, Curtis JL, Hokanson JE, Lynch DA, Make BJ, Crapo JD, Silverman EK, Bowler RP, Dransfield MT; COPDGene Investigators; ECLIPSE Study Investigators. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012; 367: 913-921. doi: 10.1056/NEJMoa1203830
2. Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest. 2014; 145: 824-832. doi: 10.1378/chest.13-1422
3. Estepar RS, Kinney GL, Black-Shinn JL, Bowler RP, Kindlmann GL, Ross JC, Kikinis R, Han MK, Come CE, Diaz AA, Cho MH, Hersh CP, Schroeder JD, Reilly JJ, Lynch DA, Crapo JD, Wells JM, Dransfield MT, Hokanson JE, Washko GR; COPDGene Study. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013; 188: 231-239. doi: 10.1164/rccm.201301-0162OC
4. Petty TL. Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. Chest. 2000; 117(5 Suppl 2): 326S-331S
5. Stone AC, Machan JT, Mazer J, Casserly B, Klinger JR. Echocardiographic evidence of pulmonary hypertension is associated with increased 1-year mortality in patients admitted with chronic obstructive pulmonary disease. Lung. 2011; 189: 207-212. doi: 10.1007/s00408-011-9293-4
6. Gologanu D, Stanescu C, Ursica T, Balea MI, Ionita D, Bogdan MA. Prevalence and Characteristics of Pulmonary Hypertension Associated with COPD-a pilot study in patients referred to a Pulmonary Rehabilitation Program Clinic. Maedica (Buchar). 2013; 8: 243-248
7. Hilde JM, Skjorten I, Grotta OJ, Hansteen V, Melsom MN, Hisdal J, Humerfelt S, Steine K. Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol. 2013; 62: 1103-1111. doi: 10.1016/j.jacc.2013.04.091
8. Tayyareci Y, Tayyareci G, Tastan CP, Bayazit P, Nisanci Y. Early diagnosis of right ventricular systolic dysfunction by tissue Doppler-derived isovolumic myocardial acceleration in patients with chronic obstructive pulmonary disease. Echocardiography. 2009; 26: 1026-1035. doi: 10.1111/j.1540-8175.2009.00925.x
9. Freixa X, Portillo K, Pare C, Garcia-Aymerich J, Gomez FP, Benet M, Roca J, Farrero E, Ferrer J, Fernandez-Palomeque C, Anto JM, Barbera JA; PAC-COPD Study Investigators. Echocardiographic abnormalities in patients with COPD at their first hospital admission. Eur Respir J. 2013; 41: 784-791. doi: 10.1183/09031936.00222511
10. Gupta NK, Agrawal RK, Srivastav AB, Ved ML. Echocardiographic evaluation of heart in chronic obstructive pulmonary disease patient and its co-relation with the severity of disease. Lung India. 2011; 28: 105-109. doi: 10.4103/0970-2113.80321
11. McLure LE, Peacock AJ. Cardiac magnetic resonance imaging for the assessment of the heart and pulmonary circulation in pulmonary hypertension. Eur Respir J. 2009; 33: 1454-1466. doi: 10.1183/09031936.00139907
12. Vonk-Noordegraaf A, Souza R. Cardiac magnetic resonance imaging: what can it add to our knowledge of the right ventricle in pulmonary arterial hypertension?. Am J Cardiol. 2012; 110(6 Suppl): 25S-31S. doi: 10.1016/j.amjcard.2012.06.013
13. Lorenz CH, Walker ES, Morgan VL, Klein SS, Graham TP Jr. Normal human right and left ventricular mass, systolic function, and gender differences by cine magnetic resonance imaging. J Cardiovasc Magn Reson. 1999; 1: 7-21
14. Grapsa J, O'Regan DP, Pavlopoulos H, Durighel G, Dawson D, Nihoyannopoulos P. Right ventricular remodelling in pulmonary arterial hypertension with three-dimensional echocardiography: comparison with cardiac magnetic resonance imaging. Eur J Echocardiogr. 2010; 11: 64-73. doi: 10.1093/ejechocard/jep169
15. Sharma B, Neilan TG, Kwong RY, Mandry D, Owens RL, McSharry D, Bakker JP, Malhotra A. Evaluation of right ventricular remodeling using cardiac magnetic resonance imaging in co-existent chronic obstructive pulmonary disease and obstructive sleep apnea. COPD. 2013; 10: 4-10. doi: 10.3109/15412555.2012.719050
16. Sanz J, Kariisa M, Dellegrottaglie S, Prat-Gonzalez S, Garcia MJ, Fuster V, Rajagopalan S. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009; 2: 286-295. doi: 10.1016/j.jcmg.2008.08.007
17. Vonk-Noordegraaf A, Marcus JT, Holverda S, Roseboom B, Postmus PE. Early changes of cardiac structure and function in COPD patients with mild hypoxemia. Chest. 2005; 127: 1898-1903. doi: 10.1378/chest.127.6.1898
18. Gao Y, Du X, Qin W, Li K. Assessment of the right ventricular function in patients with chronic obstructive pulmonary disease using MRI. Acta Radiol. 2011; 52: 711-715. doi: 10.1258/ar.2011.100449
19. Grau M, Barr RG, Lima JA, Hoffman EA, Bluemke DA, Carr JJ, Chahal H, Enright PL, Jain A, Prince MR, Kawut SM. Percent emphysema and right ventricular structure and function: the Multi-Ethnic Study of Atherosclerosis-Lung and Multi-Ethnic Study of Atherosclerosis-Right Ventricle Studies. Chest. 2013; 144: 136-144. doi: 10.1378/chest.12-1779
20. Vonk Noordegraaf A, Marcus JT, Roseboom B, Postmus PE, Faes TJ, de Vries PM. The effect of right ventricular hypertrophy on left ventricular ejection fraction in pulmonary emphysema. Chest. 1997; 112: 640-645
21. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD. 2010; 7: 32-43. doi: 10.3109/15412550903499522
22. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med. 1999; 159: 179-187. doi: 10.1164/ajrccm.159.1.9712108
23. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van Der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005; 26: 319-338. doi: 10.1183/09031936.05.00034805
24. Laboratories ATSCoPSfCPF. Ats statement: Guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002; 166: 111-117
25. Kindlmann GL, San Jose Estepar R, Smith SM, Westin CF. Sampling and visualizing creases with scale-space particles. IEEE Trans Vis Comput Graph. 2009; 15: 1415-1424. doi: 10.1109/TVCG.2009.177
26. Ross JC, San Jose Estepar R, Kindlmann G, Diaz A, Westin CF, Silverman EK, Washko GR. Automatic lung lobe segmentation using particles, thin plate splines, and maximum a posteriori estimation. Med Image Comput Comput Assist Interv. 2010; 13(Pt 3): 163-171
27. Estepar RS, Ross JC, Krissian K, Schultz T, Washko GR, Kindlmann GL. Computational vascular morphometry for the assessment of pulmonary vascular disease based on scale-space particles. Proc IEEE Int Symp Biomed Imaging. 2012: 1479-1482
28. Drake D, Gupta R, Lloyd SG, Gupta H. Right ventricular function assessment: comparison of geometric and visual method to short-axis slice summation method. Echocardiography. 2007; 24: 1013-1019. doi: 10.1111/j.1540-8175.2007.00510.x
29. Rajaram S, Swift AJ, Capener D, Elliot CA, Condliffe R, Davies C, Hill C, Hurdman J, Kidling R, Akil M, Wild JM, Kiely DG. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol. 2012; 39: 1265-1274. doi: 10.3899/jrheum.110987
30. Akcay M, Yeter E, Durmaz T, Keles T, Akar Bayram N, Uyar M, Davutoglu V, Yuksel I, Kurt M, Bozkurt E. Treatment of acute chronic obstructive pulmonary disease exacerbation improves right ventricle function. Eur J Echocardiogr. 2010; 11: 530-536. doi: 10.1093/ejechocard/jeq013
31. Rider OJ, Petersen SE, Francis JM, Ali MK, Hudsmith LE, Robinson MR, Clarke K, Neubauer S. Ventricular hypertrophy and cavity dilatation in relation to body mass index in women with uncomplicated obesity. Heart. 2011; 97: 203-208. doi: 10.1136/hrt.2009.185009
32. Gao Y, Du X, Liang L, Cao L, Yang Q, Li K. Evaluation of right ventricular function by 64-row CT in patients with chronic obstructive pulmonary disease and cor pulmonale. Eur J Radiol. 2012; 81: 345-353. doi: 10.1016/j.ejrad.2010.11.004
33. Suchon E, Tracz W, Podolec P, Pieculewicz M, Plazak W, Prokop A, Nalepa P. [Evaluation of left ventricular function in patients with chronic obstructive pulmonary disease]. Pol Arch Med Wewn. 2007; 117: 26-30
34. Barr RG, Bluemke DA, Ahmed FS, Carr JJ, Enright PL, Hoffman EA, Jiang R, Kawut SM, Kronmal RA, Lima JA, Shahar E, Smith LJ, Watson KE. Percent emphysema, airflow obstruction, and impaired left ventricular filling. N Engl J Med. 2010; 362: 217-227. doi: 10.1056/NEJMoa0808836
35. Jorgensen K, Muller MF, Nel J, Upton RN, Houltz E, Ricksten SE. Reduced intrathoracic blood volume and left and right ventricular dimensions in patients with severe emphysema: an MRI study. Chest. 2007; 131: 1050-1057. doi: 10.1378/chest.06-2245
36. Casanova C, Cote C, de Torres JP, Aguirre-Jaime A, Marin JM, Pinto-Plata V, Celli BR. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2005; 171: 591-597. doi: 10.1164/rccm.200407-867OC
37. Cordova F, O'Brien G, Furukawa S, Kuzma AM, Travaline J, Criner GJ. Stability of improvements in exercise performance and quality of life following bilateral lung volume reduction surgery in severe COPD. Chest. 1997; 112: 907-915
38. Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K, Kesten S, O'Donnell D. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest. 2005; 128: 1168-1178. doi: 10.1378/chest.128.3.1168
39. Goudie AR, Lipworth BJ, Hopkinson PJ, Wei L, Struthers AD. Tadalafil in patients with chronic obstructive pulmonary disease: a randomised, double-blind, parallel-group, placebo-controlled trial. Lancet Respir Med. 2014; 2: 293-300. doi: 10.1016/S2213-2600(14)70013-X
40. Blanco I, Santos S, Gea J, Guell R, Torres F, Gimeno-Santos E, Rodriguez DA, Vilaro J, Gomez B, Roca J, Barbera JA. Sildenafil to improve respiratory rehabilitation outcomes in COPD: a controlled trial. Eur Respir J. 2013; 42: 982-992. doi: 10.1183/09031936.00176312
41. Boeck L, Tamm M, Grendelmeier P, Stolz D. Acute effects of aerosolized iloprost in COPD related pulmonary hypertension -a randomized controlled crossover trial. PLoS One. 2012; 7: e52248. doi: 10.1371/journal.pone.0052248